Skip to main content
HOPA 2024 Main banner
Final Program


Program Book
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Wednesday, April 3, 2024
  • 7:00 AM – 8:00 AM ET
    CE Symposium: Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists
  • 7:00 AM – 8:00 AM ET
    CE Symposium: Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering Effective Therapy With Antibody Platforms
  • 7:00 AM – 8:00 AM ET
    CE Symposium:Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operational Efficiency in Multiple Myeloma
  • 8:00 AM – 12:00 PM ET
    Pre-conference: From Data to Decisions: A Masterclass in Critical Appraisal of Cancer Research
  • 12:00 PM – 1:00 PM ET
    Non-CE Symposium: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?
  • 12:00 PM – 1:00 PM ET
    Non-CE Symposium: Brukinsa (zanubrutinib) for the treatment of adult patient with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
  • 12:00 PM – 1:00 PM ET
    Non-CE Symposium: Outcomes and Economic Impact of Treatment with CABLIVI®(caplacizumab-yhdp)
  • 1:15 PM – 2:30 PM ET
    Diving into DEI: Increasing Inclusivity and Fostering Diversity in Clinical Trials
  • 1:15 PM – 2:30 PM ET
    Updates in Hematology
  • 2:45 PM – 3:30 PM ET
    President's Welcome
  • 3:45 PM – 4:45 PM ET
    Platform Research Part 1 of 4: The REMEDY Trial: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy
  • 3:45 PM – 4:45 PM ET
    Platform Research Part 2 of 4: Post-Transplant Cyclophosphamide As GVHD Prevention After Myeloablative Conditioning
  • 3:45 PM – 4:45 PM ET
    Platform Research Part 3 of 4: Survey of PGY-2 Oncology RPDs To Assess Resources and Effects on Burnout
  • 3:45 PM – 4:45 PM ET
    Platform Research Part 4 of 4: Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib
  • 3:45 PM – 4:45 PM ET
    Updates in Hodgkin Lymphoma and the Role of the Pharmacist in Management of Toxicities
  • 3:45 PM – 4:45 PM ET
    Waiting For The Rain: Practical Strategies And Ethical Considerations During Anticancer Drug Droughts
  • 4:45 PM – 7:00 PM ET
    Exhibit Hall Welcome Reception and Industry Encore Posters
  • 5:30 PM – 6:30 PM ET
    Non-CE Symposium: Managing Patients with locally advanced or metastatic KRAS G12C-mutated NSCLC
  • 5:30 PM – 6:30 PM ET
    Non-CE Symposium: Planning for Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Case-Based Symposium on Care Team Preparation and Patient Management
  • 6:00 PM – 8:00 PM ET
    AC24 Service Project: HOPA CAN Help Prevent HIV